[1]Actapoloniaepharmaceutica,1999,vol.56,p.127-133
[1]Patent:WO2016/118639,2016,A1.Locationinpatent:Paragraph0138
70-10-0
1329616-16-1
58249-25-5
14599-38-3
479073-80-8 | 5-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-thione | AA00DFC7 | MFCD11977922
469-73-8 | IFLAB-BB F1244-0003 | AA00DFIS | MFCD03731357
512810-22-9 | 4-Bromo-1-ethyl-1h-pyrazole-3-carboxylic acid | AA00DFU4 | MFCD03074558
500348-26-5 | Ethyl 5-oxo-4,5-dihydroisoxazole-4-carboxylate | AA00DG25 | MFCD09859284
489431-66-5 | 2,5-Dibromo-3-methoxypyrazine | AA00DGM7 | MFCD09909711
557788-37-1 | Ethyl(2-methoxyethyl)dimethylammonium bis(trifluoromethanesulfonyl)imide | AA00DGZB | MFCD09038873
4748-80-5 | 4-Ethyl-3-nitrobenzaldehyde | AA00DHQT | MFCD03982635
51052-79-0 | 3-(Piperidin-4-yl)propanoic acid hydrochloride | AA00DHVN | MFCD06202371
51050-54-5 | 3-CHLOROISOCOUMARIN | AA00DIBZ | MFCD11520755
4619-08-3 | 1,3-DI-n-BUTYLTETRAMETHYLDISILOXANE | AA00DIIJ